Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654
GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and National burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):582–97. https://doi.org/10.1016/S2468-1253(20)30007-8
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85– 01). Radiation Therapy Oncol Group JAMA. 1999;281(17):1623–7. https://doi.org/10.1001/jama.281.17.1623
Yang H, Wang F, Hallemeier CL, Lerut T, Fu J, Oesophageal Carcinoma. Lancet. 2024;404(10466):1991–2005. https://doi.org/10.1016/S0140-6736(24)02226-8
Xiang G, Chai GJ, Lyu B, Li ZH, Yin YT, Wang B, et al. Long-term results of induction chemotherapy for non-operable esophageal squamous cell carcinoma followed by concurrent chemoradiotherapy: a single-centre experience. Radiol Oncol. 2024;58(3):444–57. https://doi.org/10.2478/raon-2024-0038
Article CAS PubMed PubMed Central Google Scholar
Wu HS, Yu YL, Zheng QH, Liu TX, Wu YH, Wang ZP, et al. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 2021;16(1):207. https://doi.org/10.1186/s13014-021-01931-1
Article CAS PubMed PubMed Central Google Scholar
Petit C, Suissa A, Finet A, Comte A, Soltys B, Daveau C, et al. Overall treatment time assessment of radiotherapy delivered in a curative intent: A prospective study. Cancer Radiother. 2015;19(8):703–9. https://doi.org/10.1016/j.canrad.2015.04.007
Article CAS PubMed Google Scholar
Dahlke S, Steinmann D, Christiansen H, Durisin M, Eckardt A, Wegener G, et al. Impact of time factors on outcome in patients with head and neck Cancer treated with definitive Radio(Chemo)Therapy. Vivo. 2017;31(5):949–55. https://doi.org/10.21873/invivo.11152
Hallemeier CL, Moughan J, Haddock MG, Herskovic AM, Minsky BD, Suntharalingam M, et al. Association of radiotherapy duration with clinical outcomes in patients with esophageal Cancer treated in NRG oncology trials: A secondary analysis of NRG oncology randomized clinical trials. JAMA Netw Open. 2023;6(4):e238504. https://doi.org/10.1001/jamanetworkopen.2023.8504
Article PubMed PubMed Central Google Scholar
Yao JJ, Zhang F, Gao TS, Zhang WJ, Lawrence WR, Zhu BT, et al. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis. Radiother Oncol. 2019;132:178–87. https://doi.org/10.1016/j.radonc.2018.10.018
Chow R, Hasan S, Choi JI, Fox J, Chhabra AM, Marshall DC, et al. Effect of treatment interruptions on overall survival in patients with triple-negative breast cancer. J Natl Cancer Inst. 2023;115(9):1029–35. https://doi.org/10.1093/jnci/djad127
Article PubMed PubMed Central Google Scholar
Raphael MJ, Ko G, Booth CM, Brogly SB, Li WB, Kalyvas M, et al. Factors associated with chemoradiation therapy interruption and noncompletion among patients with squamous cell anal carcinoma. JAMA Oncol. 2020;6(6):881–7. https://doi.org/10.1001/jamaoncol.2020.0809
Pepin AN, Zwart A, Danner M, Ayoob M, Yung T, Collins BT, et al. Treatment interruptions during stereotactic body radiotherapy for prostate Cancer. Front Oncol. 2022;11:796496. https://doi.org/10.3389/fonc.2021.796496
Article PubMed PubMed Central Google Scholar
Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, et al. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011;81(5):813–8. https://doi.org/10.1016/j.ijrobp.2010.12.005
Chen YP, Mao YP, Zhang WN, Chen L, Tang LL, Li WF, et al. Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensitymatched analysis. Oncotarget. 2016;7(12):14973–82. https://doi.org/10.18632/oncotarget.7789
Article PubMed PubMed Central Google Scholar
Noh KW, Kim B, Choi CH, Kim TJ, Lee JW, Kim BG, et al. Effect of waiting time from pathological diagnosis to definitive concurrent chemoradiation for cervical Cancer on overall survival. Cancer Res Treat. 2022;54(1):245–52. https://doi.org/10.4143/crt.2021.023
Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10. https://doi.org/10.1016/j.radonc.2007.04.001
Mou YH, Liang P, Cheng X, He X, Zhang J, Liu LZ, et al. Influence of radiotherapy interruption on esophageal cancer with intensitymodulated radiotherapy: a retrospective study. BMC Cancer. 2024;24:646. https://doi.org/10.1186/s12885-024-12383-7
Article PubMed PubMed Central Google Scholar
Dahrouge EC, Samant S, Mirzaei R, Price A. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome. Int J Radiat Oncol Biol Phys. 2005;61(4):1071–7. https://doi.org/10.1016/j.ijrobp.2004.09.030
Jiang YT, Chen KH, Yang J, Liang ZG, Qu S, Li L, et al. Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Head Neck. 2022;44(5):1182–91. https://doi.org/10.1002/hed.27011
Waaijer A, Terhaard CH, Dehnad H, Hordijk G, Leeuwen MS, Raaymakers CP, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–6. https://doi.org/10.1016/s0167-8140(03)00036-7
León X, de Vega M, Orús C, Morán J, Vergés J, Quer M. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol. 2003;66(3):277–81. https://doi.org/10.1016/s0167-8140(03)00022-7
van Harten MC, Hoebers FJP, Kross KW, van Werkhoven ED, van den Brekel MWM, van Dijk BAC. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–8. https://doi.org/10.1016/j.oraloncology.2014.12.003
Barton BB, Morgan G, Smee R, Tiver KW, Hamilton C, Gebski V. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol. 1997;44(2):137–41. https://doi.org/10.1016/s0167-8140(97)00093-5
Article CAS PubMed Google Scholar
Brouha XD, Op De Coul B, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol. 2000;25(3):215–8. https://doi.org/10.1046/j.1365-2273.2000.00347.x
Article CAS PubMed Google Scholar
Dereje N, Addissie A, Worku A, Gebremariam A, Kantelhardt EJ, Assefa M, et al. Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in addis ababa, Ethiopia. Int J Cancer. 2021;149(6):1284–9. https://doi.org/10.1002/ijc.33689
Article CAS PubMed Google Scholar
Loureiro LV, Pontes Lde B, Callegaro-Filho D, Koch Lde O, Weltman E, Victor Eda S, et al. Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities. Arq Neuropsiquiatr. 2015;73(2):104–10. https://doi.org/10.1590/0004-282X20140202
Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol. 2000;57(2):131–6. https://doi.org/10.1016/s0167-8140(00)00257-7
Article CAS PubMed Google Scholar
Downing A, Gilthorpe MS, Dodwell D, Lawrence G, Forman D. Waiting times for radiotherapy after breast-conserving surgery and the association with survival: a path analysis. Clin Oncol (R Coll Radiol). 2011;23(7):442–8. https://doi.org/10.1016/j.clon.2011.02.004
Comments (0)